Alamar Biosciences, Inc. (California) (ALMR)
30.83
-0.93
(-2.93%)
USD |
NASDAQ |
Nov 13, 16:00
30.83
0.00 (0.00%)
After-Hours: 19:59
Alamar Biosciences Gross Profit Margin (Quarterly) : 61.54% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 61.54% |
| June 30, 2026 | 60.21% |
| March 31, 2026 | 55.53% |
| Date | Value |
|---|---|
| September 30, 2025 | 59.74% |
| June 30, 2025 | 53.09% |
| March 31, 2025 | 48.80% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Personalis, Inc. | 25.67% |
| 10X Genomics, Inc. | 75.52% |
| Champions Oncology, Inc. | 48.48% |
| Medpace Holdings, Inc. | 30.35% |
| Avantor, Inc. | 31.49% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -38.22% |
| Return on Assets | -17.54% |
| Return on Invested Capital | -19.20% |
| Profit Margin (Quarterly) | -39.77% |
| Operating Margin (Quarterly) | -45.13% |
| Return on Net Operating Assets | -48.92% |